We need to set a standard for the “terms” of radiology reports. Part 2 of 2.
Being aware of some of the factors feeding into how, when and why a radiology report might be “Preliminary” instead of “Final” was all well and good. My more immediate concern, entering telerad and on the verge of furnishing both types, was what needed to actually be in the darned things.
[[{"type":"media","view_mode":"media_crop","fid":"25296","attributes":{"alt":"","class":"media-image media-image-right","id":"media_crop_1120649306103","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2300","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 146px; width: 120px; border-width: 0px; border-style: solid; margin: 1px; float: right;","title":" ","typeof":"foaf:Image"}}]]
“Finals,” of course, were no mystery - I had been generating those ever since I had completed fellowship. Unsurprisingly, that had been precisely when my “Prelim”-generating career had ended (or, as things were working out, gone on hiatus). Especially now that I was about to dictate a nightly mix of the two varieties, it seemed I had better know what was allowable not to put into a “Prelim.”
In the abstract, this doesn’t seem too much of a philosophical toughie - stuff that makes an on-the-spot difference (such as whether a patient will get admitted, anticoagulated, surgerized, etc.) should be in the “Prelim”. A bone island or a lung granuloma, stable for 10 years, not so much.
But then come the case-by-case specifics. Not going to mention the circumaortic left renal vein in your “Prelim”? How do you know the patient won’t wind up getting an IVC filter before the morning? That extra vein could be relevant to such a procedure. Is a noncalcified 1 mm pulmonary nodule safe to not mention? What if the patient gets discharged before the “Final” report is rendered, and nobody ever tells him he needs to get it followed?
Fortunately, I didn’t need to ponder these matters on my own - the telerad world was already populated by plenty of folks who had been playing this game for years. So, while being interviewed by a Medical Director for a telerad group, I asked what their official rule was. He hemmed and hawed…for they didn’t have one. Yes, they were paying X percent less for a “Prelim” than a “Final,” and yes, there should be a different standard in terms of what constituted a QA-worthy error. But no, he had no specifics other than the notion that, for a “Prelim,” he might report fewer measurements than in a “Final.”
It wasn’t his fault, nor the telerad company’s. Nobody had solid rules on the subject. Even the on-site radiologists (and the clinicians referring to them) couldn’t seem to agree what constituted a satisfactory “Prelim.” Some wanted as close to a one-line summary (“No acute disease”) as possible. Others wanted exhaustive detail, a report good enough to be “Final” (while enjoying the discounted reading-rate negotiated for “Prelims”). Yet others held a double-standard, generating one-line “Prelims” when covering their own call but filing QA complaints whenever telerads remotely covering them did the same.
I didn’t want to run afoul of such things. I also didn’t want to be distracted while reading multitrauma cases at 4 AM as to whether a given study was “Prelim” or “Final.” So I decided, for myself, that I was just going to read all cases as if they were “Finals,” and if that meant my productivity-numbers (and paychecks) wound up being lower than they otherwise might, so be it. Surely, onsite docs wouldn’t complain about the extra level of effort I was putting in…
…Or maybe they would. Not that I’ve gotten any negative feedback regarding my “Prelims” being too Final-like in the past two and a half years of telerad work, but I’ve heard commentary out there, from the “boots on the ground” rads, that the longer, quasi-Final “Prelims” create extra work for them when they come in to the hospital the next day and review the overnight cases.
This puts me in mind of the “mission creep” with which far too many of us have become familiar, regarding the usage of STAT. Necessitating, in some cases, truly emergent cases to be nicknamed “real STAT” or “super STAT” to distinguish them from the constant stream of routine studies bearing the STAT label for no good reason.
Maybe it’s worth subdividing the “Prelim” entity to clarify what is expected from a covering radiologist, local or otherwise…and have the fees associated with them reflect this. Call the one-liners TPs or PPs (True “Prelims,” “Prelim Prelims”), for instance, and the Final-in-all-but-name reports PFs (“Prelim Finals”). I normally cringe at such bureaucratic attempts to formalize the intrinsically-informal…but unless “Prelims” vanish from the post-training world (which would make me very happy, as noted above), defining our terms a little more might be good news for us all.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
Could AI-Powered Abbreviated MRI Reinvent Detection for Structural Abnormalities of the Knee?
April 24th 2025Employing deep learning image reconstruction, parallel imaging and multi-slice acceleration in a sub-five-minute 3T knee MRI, researchers noted 100 percent sensitivity and 99 percent specificity for anterior cruciate ligament (ACL) tears.